Physician profile
Gary Kaye
NPI 1184884207
$124,243.10
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99K · 2020: $25K · 2023: $41.55 · 2024: $62.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.83 · Education: $24.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.83 |
| Education | $24.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Henry Schein, INC. | $120,382.44 | 2019-2024 | |
| Align Technology, INC. | $1,836.20 | 2019-2020 | |
| Sirona Dental, INC. | $1,500.00 | 2019 | |
| Dentsply Sirona INC | $250.79 | 2019-2020 | |
| Peter Brasseler Holdings, LLC | $93.44 | 2019 | |
| Kavo Dental Technologies LLC | $87.84 | 2020 | |
| Ultradent Products INC | $34.45 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $24.04 | 2023 | |
| Straumann USA LLC | $17.51 | 2023 | |
| Philips North America LLC | $16.39 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Kaye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.